Last month, Congressional staffers and allied NGO partners were invited to a virtual Hill briefing featuring international experts on the human and environmental impacts of deforestation, forest fires, and toxic haze during a global pandemic.
Waxman Strategies has registered under FARA, as the firm receives grant support (including for its work to support Mighty Earth campaigns) from non-profit organizations that are in turn funded by the Norwegian Agency for Development Cooperation (Norad).
At Waxman Strategies, we recognize systemic racism pervades our society. It impacts our personal biases and prejudices. And it impacts our institutions. The answer is not going to come from striving for color blindness, but from embracing and respecting different backgrounds. And we must not lose sight that white privilege exists and has existed since the dawn of our republic.
Waxman Strategies is strengthening its firmwide capabilities in political advocacy, regulatory insight, and industry expertise with the appointment of Ruth McDonald and Kahaari Kenyatta to the health policy team.
Based on the input of experts and nonprofit leaders, our white paper describes challenges in five policy areas and provides a set of policy options for policymakers to consider which could improve the sustainability of the nonprofit model and help to reduce the burden of high prescription drug prices.
Etelle Higonnet, senior director at Waxman Strategies has been named a Chevalier of France’s Ordre national du Mérite (National Order of Merit) by French President Emmanuel Macron, recognizing her work to protect the environment.
In a blog post for Health Affairs, Chairman Henry Waxman debunks the age-old industry claim that lower drug costs mean a loss of drug innovation, noting they made the same unsubstantiated claim back in the 1980s during debate on the Hatch-Waxman Act.